Impact of pharmacogenomics on the clinical laboratory

Molecular Diagnosis

Volumn 4, Issue 4, 1999, Pages 289-298

  Hess, Patrick ^a   Cooper, David ^a  

^a QUEST DIAGNOSTICS NICHOLS INSTITUTE   (United States)

Author keywords

Disease profiling; Future clinical diagnostics; Pharmacogenetics; Pharmacogenomics

Indexed keywords

GENE PRODUCT;

DNA POLYMORPHISM; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG SCREENING; PHARMACOGENOMICS; REVIEW;

EID: 0033428029     PISSN: 10848592     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1084-8592(99)80005-8     Document Type: Article

References (5)

1. Drews J: Genomic science and the medicines of tomorrow. Nat Biotechnol 1996;14:1516-1518
2. Johnson JA, Bootman JL: Drug-related morbidity and mortality. Arch Intern Med 1995;155:1949-1956
3. Thomas F, DeRibains G: Pharmacogenomics. Financial Times Professional Limited, London, 1998
4. Garrod AW:The incidence of alcaptonuria: A study in chemical individuality. Lancet 1902;2:1616-1620
5. Marshal A: Laying the foundations of personalized medicine. Nat Biotechnol 1997;15:954-957